Copper biochemistry and molecular biology

American Journal of Clinical Nutrition

Volumn 63, Issue 5, 1996, Pages

  Linder, Maria C ^a   Hazegh Azam, Maryam ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Copper; copper enzymes; copper proteins; disease; excretion; Menkes syndrome; metabolism; molecular biology; nutrition; toxicity; toxicosis; Wilson disease

Indexed keywords

ANEMIA; COPPER METABOLISM; DIETARY INTAKE; FOOD COMPOSITION; GENETIC DISORDER; HUMAN; INTOXICATION; MENKES SYNDROME; METABOLIC DISORDER; MOLECULAR BIOLOGY; NONHUMAN; NUTRIENT; REVIEW; WILSON DISEASE;

AMINO ACID SEQUENCE; ANEMIA; ANIMALS; ARTERIOSCLEROSIS; BIOLOGICAL TRANSPORT; COPPER; HEPATOLENTICULAR DEGENERATION; HUMANS; INFLAMMATION; INTESTINAL ABSORPTION; MENKES KINKY HAIR SYNDROME; MOLECULAR SEQUENCE DATA; NEOPLASMS; NUTRITION PHYSIOLOGY; PROTEINS; TISSUE DISTRIBUTION;

EID: 0029883795     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (109)

1. Linder MC. The biochemistry of copper. New York: Plenum, 1991
2. Linder MC. Nutrition and metabolism of trace elements. In: Linder MC, ed Nutritional biochemistry and metabolism. 2nd ed. New York: Elsevier, 1991:215-76.
3. Davis GK, Mertz W. Copper. In: Mertz W, ed. Trace element in human and animal nutrition. 5th ed. Vol 1. New York: Academic Press, 1987:301-64.
4. Harris ED. Copper transport: an overview. Soc Exp Biol Med 1991; 130-40
5. Scott KC, Turnlund JR Compartment model of copper metabolism in adult men. J Nutr Biochem 1994;5:342-50.
6. Johnson PE, Milne DB, Lykken GI. Effect of age and sex on copper absorption, biological half-life, and status in humans. J Clin Nutr 1992;56:917-25.
7. Dunham R, Smith HE Lead and copper - a model home approach. Proc Water Qual Technol Conf 1992 1991:341-52.
8. Goode CA. Copper and disease. In: MC Linder, ed. The biochemistry of copper. New York: Plenum, 1991:331-66.
9. Walker WR. The results of a copper bracelet clinical trial and subsequent studies. In: JRJ Sorenson, ed. Inflammatory diseases and copper. Clifton, NJ: Humana Press, 1982:469-78.
10. He G, Cao L, Wang S, Feng S. Studies on solubilization and transformation of species of Cu, Pb, Zn and Cr in simulant acid rain Chin Chem Lett 1994;5:93-4.
11. Tubbing DMJ, Admirall W, Cleven RFMJ, Iqbal M, van den Meent D, Verweij W. The contribution of complexed copper to the metabolic inhibition of algae and bacteria in synthetic media and river water Water Res 1994;28:37-44.
12. 65Cu. Am J Clin Nutr 1989;49:870-8
13. National Research Council. Recommended dietary allowances. 10th ed Washington, DC: National Academy Press, 1989.
14. Wapnir RA, Lee SY. Dietary regulation of copper absorption and storage in rats: effects of sodium, zinc and histidine-zinc. J Am Coll Nutr 1993;12:714-9.
15. Yu S, West CE, Beynen AC. Increasing intakes of iron reduce status, absorption and biliary excretion of copper in rats. Br J Nutr 1994; 71:887-95.
16. Cohen NL, Illowsky B, Linder MC. Altered copper absorption in tumor bearing and estrogen treated rats. Am J Physiol 1979;236: E309-15.
17. Hartmann HJ, Felix K, Nagel W, Weser U. Intestinal administration of copper and its transient release into venous blood serum concomitantly with metallothionein. Biometals 1993;6:115-8.
18. Kanamura K, Kashiwagi S, Mizuno T. A copper transporting P-type ATPase found in the thylakoid membrane of the cyanobacterium Synechococcus species PCC7942. Mol Microbiol 1994;13:369-77.
19. Linder MC, Weiss KC, Vu HM, Rucker RB. Structure and function of transcuprein in transport of copper by mammalian blood plasma. In: Hurley LC, Lonnerdal B, Keen C, eds. Trace elements in man and animals (TEMA-6). New York: Plenum, 1987:141-4.
20. Owen CA Jr. Biochemical aspects of copper. Copper deficiency and toxicity. Physiological aspects of copper. Park Ridge, NJ: Noyes, 1982.
21. Weiss KC, Linder MC. Copper transport in rats involving a new plasma protein. Am J Physiol 1985;249:E77-88.
22. Wirth PL, Linder MC. Distribution of copper among multiple components of human serum. J Natl Cancer Inst 1985;75:277-84.
23. Barrow L, Tanner MS. Copper distribution among serum proteins in paediatric liver disorders and malignancies. Eur J Clin Invest 1988; 18:555-60.
24. Tsai MT, Dinh CT, Linder MC. Interactions of transcuprein and albumin in copper transport. FASEB J 1992;6:A1095(abstr).
25. Vargas EJ, Shoho AR, Linder MC. Copper transport in the Nagase analbuminemic rat. Am J Physiol 1994;267:G259-69.
26. Lau S, Sarkar B. Comparative studies of manganese(II)-, nickel(II)-, zinc(II)-, copper(II)-, cadmium(II)-, and iron(III)-binding components in human cord and adult sera. Can J Biochem Cell Biol 1984;62:449-55.
27. Montaser A, Tetreault C, Linder MC. Comparison of copper binding proteins in dog serum with those in other species. Proc Soc Exp Biol Med 1992;200:321-9.
28. Ettinger MJ, Darwish HM, Schmitt RC. Mechanism of copper transport from plasma to hepatocytes. Fed Proc 1986;45:2800-4.
29. McArdle HJ, Guthrie JR, Ackland ML, Danks DM. Albumin has no role in the uptake of copper by human fibroblasts. J Inorg Biochem 1987;31:123-31
30. Dancis A, Yuan DS, Haile D, et al. Molecular characterization of a copper transport protein in S cerevisiae: an unexpected role for copper in iron transport. Cell 1994;76:393-402
31. Cha J, Cooksey DA. Copper resistance in Pseudomonas syringae mediated by periplasmic and outer membtane proteins. Proc Natl Acad Sci U S A 1991;88.8915-9.
32. Odermatt A, Suter HK, Krapf R, Solioz M. Primary structure of two P-type ATPases involved in copper homeostasis in Enterococcus hirae. J Biol Chem 1993;268:12775-9.
33. Dancis A, Haile D, Yuan DS, Klausner RD. The Saccharomyces cerevisiae copper transport protein (Ctr1p). Biochemical characteriation, regulation by copper, and physiologic role in copper uptake. J Biol Chem 1994;269:25660-7.
34. Campbell CH, Brown R, Linder MC. Circulating ceruloplasmin is an important source of copper for normal and malignant cells. Biochim Biophys Acta 1981;678:27-38.
35. Lee SH, Lancey R, Montaser A, Madani N, Linder MC. Ceruloplasmin and copper transport during the latter part of gestation in the rat. Proc Soc Exp Biol Med 1993;203:428-39.
36. Harris ZL, Takahashi Y, Miyajima H, Serizawa M, MacGillivray RTA, Gitlin JD. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci U S A 1995; 92:2539-43.
37. Yoshida K, Furihata K, Takeda S, et al. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nature Genet 1995;9:267-72.
38. Fischer AC, Goode CA. Interaction of bovine ceruloplasmin with erythrocytes. Prep Biochem 1994;24:151-65.
39. Percival SS, Harris ED. Copper transport from ceruloplasmin: characterization of the cellular uptake mechanism. Am J Physiol 1990; 258:C140-6.
40. Davidson LA, Harris ED. Characterization of a particulate pathway for copper in K562 cells Biochim Biophys Acta 1994;1221:1-6.
41. 67Cu. Am J Physiol 1986;251:E551-5.
42. Harada M, Sakisaka S, Yoshitake M, et al. Biliary copper excretion in acutely and chronically copper-loaded rats. Hepatology 1993;17: 111-7.
43. DeDuve C, Wattiaux R. Functions of lysosomes. Annu Rev Physiol 1966;28:435-92.
44. Gross JB, Myers BM, Kost LJ, Kuntz SM, LaRusso NF. Biliary copper excretion by hepatocyte lysosomes in the rat. J Clin Invest 1989;83:30-9.
45. Evering W, Haywood S, Brenner I, Trafford J, Wood A. The protective role of metallothionein in copper overload. In: B Momcilovic, ed. Trace elements in man and animal 7. Zagreb, Yugoslavia: Institute for Medical Research and Occupational Health, 1991:2/8-2/9.
46. Nederbragt H. Effect of the glutathione-depleting agents diethylmaleate, phorone and buthionine sulfoxamine on biliary copper excretion in rats. Biochem Pharmacol 1989;38:3399-406.
47. Dijkstra M, Kuipers F, Smit EP, Havinga R, Vonk RJ. The role of glutathione in bile secretion of endogenous trace elements in rats. J Lab Clin Med 1993;121:751-8.
48. Kressner MS, Stockert RJ, Morell AG, Sternlieb I. Origins of biliary copper. Hepatology 1984;4:867-70.
49. Iyengar V, Brewer GJ, Dick RD, Owyang C. Studies of cholecystokinin-stimulated biliary secretions reveal a high molecular weight copper binding substance in normal subjects that is absent in patients with Wilson's disease. J Lab Clin Med 1988;111:267-74.
50. Chowrimootoo GFE, Seymour CA. The role of caeruloplasmin in copper excretion. Biochem Soc Trans 1994;22:190S(abstr).
51. Tavassoli M, Kishimoto T, Kataoka M. Liver endothelium mediates the hepatocyte's uptake of ceruloplasmin. J Cell Biol 1986;102: 1298-303.
52. Bode AM, Miller LA, Faber J, Saari JT. Mitochondrial respiration in heart, liver, and kidney of copper deficient rats. J Nutr Biochem 1992;3:668-72.
53. Bermingham-McDonogh O, Gralla EB, Valentine JS. The copper, zinc-superoxide dismutase gene of Saccharomyces cerevisiae: cloning, sequencing, and biological activity. Proc Natl Acad Sci U S A 1988;85:4789-93.
54. Maitre B, Jornot L, Junod AF. Effects of inhibition of catalase and superoxide dismutase activity on antioxidant enzyme mRNA levels. Am J Physiol 1993;265:L636-43
55. Yang G, Chan PH, Chen J, et al. Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke 1994;25:165-70.
56. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotropic lateral sclerosis. Nature 1993;362:59-62.
57. Winge DR, Miklossy K. Differences in the polymorphic forms of metallothionein. Arch Biochem Biophys 1982;214:80-8.
58. Felix K, Lengfelder, Hartmann H-J, Weser U. A pulse radiolytic study on the reaction of hydroxyl and superoxide radicals with yeast Cu(I) thionein. Biochim Biophys Acta 1993;1203:104-8.
59. Satoh M, Naganuma A, Imura N. Effect of preinduction of metallothionein on paraquat toxicity in mice. Arch Toxicol 1992;66:145-8.
60. Miesel R, Hartmann H-J. Weser U. Antiinflammatory reactivity of copper(I)-thionein. Inflammation 1990;14:471-83.
61. Miura T, Muraoka S, Ogiso T. Adriamycin-induced lipid peroxidation of erythrocyte membranes in the presence of ferritin and the inhibitory effect of ceruloplasmin. Biol Pharm Bull 1993;16:664-7.
62. Linder MC. Interactions between copper and iron in mammalian metabolism. In: BE Elsenhans, W Forth, K Schumann, eds. Metal-metal interactions. Gutersloh, Germany: Bertelsheim Foundation, 1994:11-41.
63. Frieden E. Ceruloplasmin; a multifunctional metalloprotein of vertebrate plasma. In: H Sigel, ed. Metal ions in biological systems. Vol 13. New York: Marcel Dekker, 1981.117-42.
64. De Silva DM, Aust SD. Ferritin and ceruloplasmin in oxidative damage: review and recent findings. Can J Physiol Pharmacol 1993; 71:715-20.
65. Askwith CE, Eide D, Van Ho A, et al. The FET3 gene of S. cerevisiae encodes a multicopper oxidase required for ferrous iron uptake. Cell 1994;76:403-10.
66. Dancis A, Yuan DS, Moehle C, et al. Molecular characterization of a copper transport protein in S. cerevisiae: an unexpected role for copper in iron transport. Cell 1994;76:393-402.
67. Ehrenwald E, Chisholm MG, Fox PL. Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J Clin Invest 1994;93: 1493-501.
68. Swain JA, Darley-Usmar V, Gutteridge JMC. Peroxynitrite releases copper from caeruloplasmin: implications for atherosclerosis FEBS Lett 1994;342:49-52.
69. Abdalla DSP, Campa A, Monterio HP. Low density lipoprotein oxidation by stimulated neutrophils and ferritin. Atherosclerosis 1992;97:149-59.
70. Lamb DJ, Leake DS. Acidic pH enables caeruloplasmin to catalyse the modification of low-density Hpoprotein. FEBS Lett 1994;338: 122-6.
71. Linder MC, Cerveza P, Wooten L, Sun J, Shulze R, Wang T-P. Ceruloplasmin in milk and amniotic fluid. FASEB J 1994;8: A711(abstr).
72. Middleton RB, Linder MC. Synthesis and turnover of ceruloplasmin in rats treated with 17-β-estradiol. Arch Biochem Biophys 1993;302: 362-8.
73. Karp BI, Roboz M, Linder MC. Regulation of ceruloplasmin and copper turnover, by estrogens and tumors, in the rat. J Nutr Growth Cancer 1986;3:47-55.
74. Linder MC, Moor JR, Wright K. Ceruloplasmin assays in diagnosis and treatment of human lung, breast and gastrointestinal cancer. J Natl Cancer Inst 1981;67:263-75.
75. Fife RS, Kluve-Beckerman B, Houser DS, et al. Evidence that a 550,000 dalton cartilage matrix glycoprotein is a chondrocyte membrane associated protein closely related to ceruloplasmin. J Biol Chem 1993;268:4407-11.
76. Fife RS, Moody S, Houser D, Proctor C. Studies of copper transport in cultured bovine chondrocytes. Biochim Biophys Acta 1994;1201: 19-22.
77. Janes SM, Mu D, Wemmer D, et al. A new redox cofactor in eukaryotic enzymes: 6-hydroxy dopa at the active site of bovine serum amine oxidase. Science 1990;248:981-7.
78. Prohaska JR, Bailey WR. Persistent regional changes in brain copper, cuproenzymes and catecholamines following perinatal copper deficiency in mice. J Nutr 1993;123:1226-34.
79. Prohaska JR, Bailey WR. Regional specificity in alterations of rat brain copper and catecholamines following perinatal copper deficiency. J Neurochem 1994;63:1551-7
80. Linder MC. Changes in the distribution and metabolism of copper in cancer: a review. J Nutr Growth Cancer 1983;1:27-38.
81. Klevay LM. Ischemic heart disease: toward a unified theory. In: Kies C, ed. Boca Raton, FL: CRC Press, 1990:223-67.
82. Kaler SG, Gallo LK, Proud VK, et al. Occipital horn syndrome and a mild Menkes phenotype associate with splice site mutations at the MNK locus. Nature Genet 1994;8:195-202.
83. Mercer JFB, Grimes A, Ambrosini L, et al. Mutation in the murine homologue of the Menkes gene in dappled and blotchy mice. Nature Genet 1994;6:374-8.
84. Yamaguchi Y, Heiny ME, Gitlin JD. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. Biochem Biophys Res Comm 1993;197:271-7.
85. Brewer GJ, Yuzbasiyan-Gurkan V. Wilson disease Medicine 1992; 71:139-64.
86. Bull PC, Thomas GR, Rommens JM, Forbes JR, Wilson Cox D. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nature Genet 1993;5:327-37.
87. Tanzi RE, Petrukhin K, Chernov I, et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nature Genet 1993;5:344-8.
88. Stewart EA, White A, Tomfohrde S, et al. Polymorphic microsatellites and Wilson Disease (WD). Am J Hum Genet 1993;53:864-73.
89. Petrukhin K, Fischer SG, Pirastu M, et al. Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. Nature Genet 1993;5:338-43.
90. Thomas GR, Bull PC, Robert EA, Walshe JM, Cox DW. Haplotype studies in Wilson disease. Am J Hum Genet 1994;54:71-8.
91. Chu N-S, Hung T-O. Geographic variations in Wilson's disease. J Neurol Sci 1993;117:1-7.
92. Yuzbasian-Gurkian V, Johnson V, Brewer GJ. Diagnosis and characterization of presymptomatic patients with Wilson's disease and the use of molecular genetics to aid in the diagnosis. J Lab Clin Med 1991;118:458-65.
93. Thomas GR, Forbes JR, Roberts EA, et al. The Wilson disease gene: spectrum of mutations and their consequences. Nature Genet 1995; 9:210-7.
94. Yukitoshi Y, Heiny ME, Shimizu N, Aoki T, Gitlin JD. Expression of the Wilson disease gene is deficient in the Long-Evans Cinnamon rat. Biochem J 1994;301:1-1.
95. Yamada T, Agui T, Suzuki Y, Sato M, Matsumoto K. Inhibition of the copper incorporation into ceruloplasmin leads to the deficiency in serum ceruloplasmin activity in Long-Evans Cinnamon mutant rat. J Biol Chem 1993;268:8965-71.
96. Suzuki M, Aoki T. Impaired hepatic copper homeostasis in Long-Evans Cinnamon rats: reduced biliary excretion of copper. Pediatr Res 1994;35:598-601.
97. Gaitskhoki VS, Kisselev OI, Moshkov KA, et al. On the defect of synthesis of ceruloplasmin in the liver polyribosomes in Wilson's disease. Biochem Genet 1975;13:533-51.
98. Schilsky ML, Stockert RJ, Sternlieb I. Pleiotropic effect of LEC mutation: a rodent model of Wilson's disease. Am J Physiol 1994; 266:G907-13.
99. Bull PC, Cox DW. Wilson disease and Menkes disease: new handles on heavy-metal transport. Trends Genet 1994;10:246-52.
100. Solioz M, Odermatt A, Krapf R. Copper pumping ATPase: common concepts in bacteria and man. FEBS Lett 1994;346:44-7.
101. Mercer J, Livingston J, Hall B, et al. Isolation of a partial candidate gene for Menkes disease by positional cloning. Nature Genet 1993; 3:20-5.
102. Vulpe C, Levinson B, Whitney S, Packman S, Gitschier J. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nature Genet 1993;3:7-13.
103. Chelly J, Turner Z, Tonnesen T, et al. Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein. Nature Genet 1993;3:14-9.
104. Chang WF, Wu FM, Shyu JJ, Hung J, Tsay CE, Lin HK. Clinical and pathological studies of swine copper intoxication. Zhonghua Minguo Shouyi Xuehui Zazhi 1992;18:97-108 (CA 118:249416).
105. Levinson B, Vulpe C, Elder B, et al. The mottled gene is the mouse homologue of the Menkes disease gene. Nature Genet 1994;6:369-73.
106. Kadiiska MB, Hanna PM, Mason RP. In vivo ESR spin trapping evidence for hydroxyl radical-mediated toxicity of paraquat and copper in rats. Toxicol Appl Pharmacol 1993;123:187-92.
107. Lind SE, McDonagh JR, Smith CJ. Oxidative inactivation of plasmin and other serine proteases by copper and ascorbate. Blood 1993;82: 1522-31.
108. Shah MA, Bergethon PR, Boak AM, Gallop PM, Kagan HM. Oxidation of peptidyl lysine by copper complexes of pyrroloquinoline quinone and other quinones. A model for oxidative pathochemistry. Biochim Biophys Acta 1992;1159:311-8.
109. Kadiiska MA, Hanna PM, Jordan SJ, Mason RP. Electron spin resonance evidence for free radical generation in copper-treated vitamin B- and selenium-deficient rats: in vivo spin-trapping investigation. Mol Pharmacol 1993;44:222-7.